BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18077053)

  • 1. Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer.
    Frías C; García-Aranda C; De Juan C; Morán A; Ortega P; Gómez A; Hernando F; López-Asenjo JA; Torres AJ; Benito M; Iniesta P
    Lung Cancer; 2008 Jun; 60(3):416-25. PubMed ID: 18077053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status.
    Fernández-Marcelo T; Gómez A; Pascua I; de Juan C; Head J; Hernando F; Jarabo JR; Calatayud J; Torres-García AJ; Iniesta P
    J Exp Clin Cancer Res; 2015 Aug; 34(1):78. PubMed ID: 26250468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
    Storti CB; de Oliveira RA; de Carvalho M; Hasimoto EN; Cataneo DC; Cataneo AJM; De Faveri J; Vasconcelos EJR; Dos Reis PP; Cano MIN
    Exp Mol Pathol; 2020 Feb; 112():104354. PubMed ID: 31837325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere length modulation in human astroglial brain tumors.
    La Torre D; Conti A; Aguennouz MH; De Pasquale MG; Romeo S; Angileri FF; Cardali S; Tomasello C; Alafaci C; Germanò A
    PLoS One; 2013; 8(5):e64296. PubMed ID: 23691191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
    Hsu CP; Ko JL; Shai SE; Lee LW
    Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA repair factors and telomere-chromosome integrity in mammalian cells.
    Hande MP
    Cytogenet Genome Res; 2004; 104(1-4):116-22. PubMed ID: 15162024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition.
    Fernández-Marcelo T; Morán A; de Juan C; Pascua I; Head J; Gómez A; Hernando F; López-Asenjo JA; Hernández S; Sánchez-Pernaute A; Torres AJ; Benito M; Iniesta P
    Oncology; 2012; 82(3):153-64. PubMed ID: 22433385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage.
    Ballal RD; Saha T; Fan S; Haddad BR; Rosen EM
    J Biol Chem; 2009 Dec; 284(52):36083-36098. PubMed ID: 19797051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs.
    Espejel S; Klatt P; Ménissier-de Murcia J; Martín-Caballero J; Flores JM; Taccioli G; de Murcia G; Blasco MA
    J Cell Biol; 2004 Nov; 167(4):627-38. PubMed ID: 15545322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Kitadai Y; Haruma K; Chayama K; Tahara E; Yasui W
    Pathobiology; 2001; 69(4):219-24. PubMed ID: 12007281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
    Lin X; Gu J; Lu C; Spitz MR; Wu X
    Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
    Hsu CP; Hsu NY; Lee LW; Ko JL
    Eur J Cancer; 2006 Jul; 42(10):1466-74. PubMed ID: 16737810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of telomeric repeat binding factor 2 enhances tumor radiosensitivity regardless of telomerase status.
    Yang X; Li Z; Yang L; Lei H; Yu H; Liao Z; Zhou F; Xie C; Zhou Y
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1545-52. PubMed ID: 25609072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas.
    Wu TC; Lin P; Hsu CP; Huang YJ; Chen CY; Chung WC; Lee H; Ko JL
    Lung Cancer; 2003 Aug; 41(2):163-9. PubMed ID: 12871779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length, telomeric proteins and DNA damage repair proteins are differentially expressed between primary lung tumors and their adrenal metastases.
    Raynaud CM; Mercier O; Commo F; Dartevelle P; Gomez-Roca C; de Montpreville V; Sabatier L; Soria JC
    Lung Cancer; 2009 Aug; 65(2):144-9. PubMed ID: 19091442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
    Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
    Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
    Yuan P; Huang S; Bao FC; Cao JL; Sheng HX; Shi L; Lv W; Hu J
    Eur J Cancer; 2019 Oct; 120():10-19. PubMed ID: 31446212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas.
    Vageli D; Daniil Z; Dahabreh J; Karagianni E; Vamvakopoulou DN; Ioannou MG; Scarpinato K; Vamvakopoulos NC; Gourgoulianis KI; Koukoulis GK
    Lung Cancer; 2009 Jun; 64(3):282-8. PubMed ID: 19056144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening.
    Wu Y; Zacal NJ; Rainbow AJ; Zhu XD
    DNA Repair (Amst); 2007 Feb; 6(2):157-66. PubMed ID: 17055345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.